Ratings by UBS (Eliana Merle)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 11/7/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | BioNTech | BNTX | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/23/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 9/23/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 9/22/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2025 | 89bio Inc. | ETNB | Maintain | Buy (Buy) |
|
Details | ||
| 9/16/2025 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 9/11/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 9/10/2025 | Gossamer Bio Inc. | GOSS | Upgrade | Buy (Neutral) |
2.66 (0.50) |
-81.2% | Details | |
| 8/13/2025 | Altimmune | ALT | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2025 | Rapt Therapeutics | RAPT | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/12/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2025 | AnaptysBio | ANAB | Maintain | Neutral (Neutral) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 8/5/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 7/29/2025 | PTC Therapeutics | PTCT | Maintain | Buy (Buy) |
|
Details | ||
| 7/21/2025 | Sarepta Therapeutics | SRPT | Downgrade | Neutral (Buy) |
14.08 (16.71) |
18.68% | Details | |
| 7/14/2025 | PTC Therapeutics | PTCT | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2025 | Altimmune | ALT | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2025 | CureVac | CVAC | Downgrade | Neutral (Buy) |
5.36 (4.66) |
-13.06% | Details | |
| 6/25/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 6/16/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2025 | BioNTech | BNTX | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/29/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2025 | Rapt Therapeutics | RAPT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/15/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2025 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 4/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2025 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/27/2025 | Ascendis Pharma | ASND | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2025 | Sarepta Therapeutics | SRPT | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 2/27/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 2/20/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (Buy) |
|
Details | ||
| 2/19/2025 | Moderna | MRNA | Maintain | Buy (Buy) |
|
Details | ||
| 2/12/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 1/31/2025 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2025 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Neutral (N/A) |
|
Details | ||
| 1/8/2025 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Tyra Biosciences | TYRA | New Coverage | Buy (N/A) |
16.06 (35.04) |
118.18% | Details | |
| 1/7/2025 | Ascendis Pharma | ASND | New Coverage | Buy (N/A) |
140.28 (240.65) |
71.55% | Details | |
| 12/13/2024 | AnaptysBio | ANAB | Maintain | Neutral (N/A) |
|
Details | ||
| 11/25/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2024 | Inventiva SA | IVA | New Coverage | Neutral (N/A) |
2.77 (4.60) |
66.06% | Details | |
| 11/12/2024 | Sagimet Biosciences Inc | SGMT | New Coverage | Buy (N/A) |
5.94 (5.41) |
-8.92% | Details | |
| 11/12/2024 | Altimmune | ALT | New Coverage | Buy (N/A) |
7.68 (3.54) |
-53.91% | Details | |
| 11/4/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | AnaptysBio | ANAB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | Rapt Therapeutics | RAPT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/20/2024 | Zentalis Pharmaceuticals | ZNTL | Downgrade | Neutral (Buy) |
4.14 (2.30) |
-44.44% | Details | |
| 6/7/2024 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2024 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 4/2/2024 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Buy) |
6.87 (58.02) |
744.54% | Details | |
| 2/14/2024 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Buy) |
32.21 (32.48) |
0.84% | Details | |
| 12/21/2023 | Kodiak Sciences Inc. | KOD | Maintain | Neutral (N/A) |
|
Details | ||
| 11/28/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2023 | AnaptysBio | ANAB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2023 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2023 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Buy (N/A) |
87.68 (61.12) |
-30.29% | Details | |
| 8/28/2023 | 89bio Inc. | ETNB | New Coverage | Buy (N/A) |
16.52 (14.84) |
-10.17% | Details | |
| 8/28/2023 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
47.97 (54.74) |
14.11% | Details | |
| 8/14/2023 | CymaBay Therapeutic | CBAY | New Coverage | Buy (N/A) |
12.96 (32.48) |
150.62% | Details | |
| 7/27/2023 | Kodiak Sciences Inc. | KOD | Downgrade | Neutral (Buy) |
3.63 (25.00) |
588.71% | Details | |
| 6/26/2023 | Moderna | MRNA | Upgrade | Buy (Neutral) |
120.48 (32.17) |
-73.3% | Details | |
| 5/19/2023 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Iveric Bio | ISEE | Downgrade | Neutral (Buy) |
38.05 (39.95) |
4.99% | Details | |
| 3/15/2023 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2022 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2022 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Iveric Bio | ISEE | New Coverage | Buy (N/A) |
10.51 (39.95) |
280.11% | Details | |
| 4/6/2022 | Gossamer Bio Inc. | GOSS | New Coverage | Buy (N/A) |
8.75 (2.66) |
-69.6% | Details | |
| 3/17/2022 | uniQure BV | QURE | Upgrade | Buy (Neutral) |
15.89 (14.27) |
-10.2% | Details | |
| 1/21/2022 | Moderna | MRNA | New Coverage | Neutral (N/A) |
167.52 (52.52) |
-68.65% | Details | |
| 1/5/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2021 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Buy (N/A) |
55.09 (4.14) |
-92.49% | Details | |
| 5/21/2021 | Kadmon Holdings | KDMN | New Coverage | Buy (N/A) |
3.75 (9.50) |
153.33% | Details | |
| 5/21/2021 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
40.10 (83.49) |
108.2% | Details | |
| 5/21/2021 | AnaptysBio | ANAB | New Coverage | Neutral (N/A) |
24.55 (43.20) |
75.97% | Details | |
| 5/21/2021 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
54.97 (65.36) |
18.9% | Details | |
| 5/21/2021 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
63.79 (13.60) |
-78.68% | Details | |
| 5/21/2021 | uniQure BV | QURE | New Coverage | Neutral (N/A) |
32.79 (14.27) |
-56.48% | Details |
